6:20 PM
Dec 06, 2012
 |  BC Extra  |  Company News

Moderna debuts, unveils mRNA platform

Moderna Therapeutics Inc. (Cambridge, Mass.) emerged from stealth mode on Thursday with a pipeline of 24 modified mRNA therapeutic programs in preclinical development and said it has raised more than $40 million since its inception last year. The...

Read the full 175 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >